JPWO2021095824A1 - - Google Patents

Info

Publication number
JPWO2021095824A1
JPWO2021095824A1 JP2021556158A JP2021556158A JPWO2021095824A1 JP WO2021095824 A1 JPWO2021095824 A1 JP WO2021095824A1 JP 2021556158 A JP2021556158 A JP 2021556158A JP 2021556158 A JP2021556158 A JP 2021556158A JP WO2021095824 A1 JPWO2021095824 A1 JP WO2021095824A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021556158A
Other versions
JP7376048B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021095824A1 publication Critical patent/JPWO2021095824A1/ja
Application granted granted Critical
Publication of JP7376048B2 publication Critical patent/JP7376048B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
JP2021556158A 2019-11-15 2020-11-12 大腸癌の診断を補助する方法、キット及びバイオマーカー Active JP7376048B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019206727 2019-11-15
JP2019206727 2019-11-15
PCT/JP2020/042344 WO2021095824A1 (ja) 2019-11-15 2020-11-12 大腸癌の診断を補助する方法、キット及びバイオマーカー

Publications (2)

Publication Number Publication Date
JPWO2021095824A1 true JPWO2021095824A1 (ja) 2021-05-20
JP7376048B2 JP7376048B2 (ja) 2023-11-08

Family

ID=75912738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021556158A Active JP7376048B2 (ja) 2019-11-15 2020-11-12 大腸癌の診断を補助する方法、キット及びバイオマーカー

Country Status (4)

Country Link
EP (1) EP4059954A4 (ja)
JP (1) JP7376048B2 (ja)
CN (1) CN114729937A (ja)
WO (1) WO2021095824A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023162878A1 (ja) * 2022-02-24 2023-08-31 学校法人日本医科大学 膵がんの診断補助方法、膵がん検出用のバイオマーカー、大腸がんの診断補助方法、又は、大腸がん検出用のバイオマーカー

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015184168A (ja) * 2014-03-25 2015-10-22 三菱化学株式会社 大腸癌マーカー及び大腸癌検出方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100475642B1 (ko) * 2001-12-29 2005-03-10 한국생명공학연구원 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트
JP2005184168A (ja) 2003-12-17 2005-07-07 Mitsubishi Electric Corp 映像符号化装置および映像符号化方法
KR100767018B1 (ko) * 2006-05-15 2007-10-12 한국생명공학연구원 종양 발생 및 전이에 관여하는 당단백질의 당쇄 변화를측정하는 방법
WO2009075883A2 (en) * 2007-12-12 2009-06-18 University Of Georgia Research Foundation, Inc. Glycoprotein cancer biomarker
JP5263979B2 (ja) * 2010-01-21 2013-08-14 株式会社Ｊ−オイルミルズ 大腸癌の判別方法
EP2722672B1 (en) 2011-06-15 2019-02-20 Sanyo Chemical Industries, Ltd. Assay method using magnetic silica particles and reagent for said assay method
JP6343560B2 (ja) 2012-09-05 2018-06-13 富士フイルム和光純薬株式会社 乳癌の判定方法
JPWO2016021729A1 (ja) * 2014-08-08 2017-06-29 国立大学法人北海道大学 グリオーマの診断マーカー、判別方法、診断方法、糖鎖マーカーを検出する方法及び糖鎖マーカー
WO2017019588A1 (en) 2015-07-28 2017-02-02 The Johns Hopkins University Compositions and methods for detecting pancreatic cancer
JP6502534B2 (ja) 2016-08-19 2019-04-17 公立大学法人横浜市立大学 糖タンパク質のｎ結合型糖鎖の解析方法及び解析システム

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015184168A (ja) * 2014-03-25 2015-10-22 三菱化学株式会社 大腸癌マーカー及び大腸癌検出方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CORMAC MCCARTHY: "The Role and Importance of Glycosylation of Acute Phase Proteins with Focus on Alpha-1 Antitrypsin i", J. PROTEOME RES, vol. 13, JPN6023018615, 3 June 2014 (2014-06-03), pages 3131 - 3143, ISSN: 0005059303 *
HAIDI YIN: "Quantitative Analysis of α-1-Antitrypsin Glycosylation Isoforms in HCC Patients Using LC-HCD-PRM-MS", ANAL. CHEM, vol. 92, JPN6023018616, 19 May 2020 (2020-05-19), pages 8201 - 8208, ISSN: 0005059304 *
JABERIE HAJAR ET AL.: "Evaluation of Alpha 1-Antitrypsin for the Early Diagnosis of Colorectal Cancer", PATHOLOGY & ONCOLOGY RESEARCH, vol. 26, no. 2, JPN6020047861, 10 June 2019 (2019-06-10), pages 1165 - 1173, XP037145028, ISSN: 0005059302, DOI: 10.1007/s12253-019-00679-0 *
L. RENEE RUHAAK: "Targeted Biomarker Discovery by High Throughput Glycosylation Profiling of Human Plasma Alpha1- Anti", PLOS ONE, vol. 8, no. 9, JPN6023018617, 9 September 2013 (2013-09-09), pages 73082, ISSN: 0005059305 *

Also Published As

Publication number Publication date
EP4059954A4 (en) 2023-05-24
CN114729937A (zh) 2022-07-08
WO2021095824A1 (ja) 2021-05-20
JP7376048B2 (ja) 2023-11-08
EP4059954A1 (en) 2022-09-21

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ja)
BR112021013854A2 (ja)
BR112021018450A2 (ja)
BR112019016141A2 (ja)
AU2020104490A4 (ja)
BR112019016138A2 (ja)
BR112019016142A2 (ja)
BR112021018168A2 (ja)
BR112021017728A2 (ja)
BR112021008711A2 (ja)
BR112021018102A2 (ja)
BR112021018452A2 (ja)
BR112021012348A2 (ja)
BR112021018250A2 (ja)
BR112021018084A2 (ja)
BR112021018093A2 (ja)
BR112021013944A2 (ja)
BR112021013128A2 (ja)
BR112021018484A2 (ja)
BR112021017732A2 (ja)
JPWO2021095824A1 (ja)
BR112021015080A2 (ja)
BR112021017949A2 (ja)
BR112021017983A2 (ja)
BR112021016205A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220518

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20220712

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230516

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230714

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230919

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231018

R150 Certificate of patent or registration of utility model

Ref document number: 7376048

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150